Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PIK3CA H1047R + PIK3C2B amplification
i
Other names:
PIK3C2B, Phosphatidylinositol-4-Phosphate 3-Kinase Catalytic Subunit Type 2 Beta, C2-PI3K, Phosphatidylinositol 4-Phosphate 3-Kinase C2 Domain-Containing Subunit Beta, Phosphoinositide-3-Kinase, Class 2, Beta Polypeptide, Phosphoinositide 3-Kinase-C2-Beta, PtdIns-3-Kinase C2 Subunit Beta, PI3K-C2-Beta, PI3K-C2beta, Phosphatidylinositol-4-Phosphate 3-Kinase, Catalytic Subunit Type 2 Beta, Phosphatidylinositol 3-Kinase C2 Domain-Containing Beta Polypeptide, PTDINS-3-Kinase C2 Beta, PIK3CA, Phospha
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5290
;
5287
Related biomarkers:
Expression
Mutation
CNA
Others
‹
PIK3CA mutation + HR positive (16)
PIK3CA mutation + ER positive (10)
PIK3CA mutation + PTEN deletion (5)
ER positive + PIK3CA H1047R (3)
HR-positive + PIK3CA wild-type (3)
PIK3CA exon 20 mutation + HR positive (3)
BRAF V600E + PIK3CA mutation + SMAD4 mutation + MSI-H/dMMR (2)
PIK3CA mutation + ER negative (2)
PIK3CA mutation + HR negative (2)
PIK3CA mutation + MSI-L/dMMR (2)
TMB-H + PIK3CA mutation (2)
CCNE1 overexpression + PIK3CA muattion + ER positive (1)
CCNE2 overexpression + PIK3CA mutation + ER positive (1)
EGFR L858R + HER-2 amplification + PIK3CA overexpression (1)
EGFR exon 19 deletion + PTEN deletion + PIK3CA overexpression (1)
ER negative + HER-2 positive + PGR positive + PIK3CA mutation (1)
ER positive + ESR1 mutation + PIK3CA mutation (1)
ESR1 mutation + PIK3CA mutation + HR positive (1)
HR positive + PIK3CA exon 10 mutation (1)
HRAS overexpression + PIK3CA amplification (1)
HRAS overexpression + PIK3CA mutation (1)
KRAS mutation + PIK3CA wild-type (1)
MET amplification + PIK3CA mutation (1)
MTAP deletion + PIK3CA mutation (1)
MYB fusion + PIK3CA mutation (1)
PD-L1 expression + PIK3CA mutation (1)
PIK3CA E542K + HR positive (1)
PIK3CA E542Q + TMB-H + MSI-H/dMMR (1)
PIK3CA H1047R + HER-2 amplification (1)
PIK3CA R88Q + PD-L1 expression (1)
PIK3CA amplification + PIK3CA mutation + HR positive (1)
PIK3CA exon 7 mutation + HR positive (1)
PIK3CA exon 9 mutation + HR positive (1)
PIK3CA mutation + ALK fusion (1)
PIK3CA mutation + ALK positive (1)
PIK3CA mutation + BRAF wild-type (1)
PIK3CA mutation + ESR1 wild-type (1)
PIK3CA mutation + HER-2 amplification (1)
PIK3CA mutation + HER-2 positive (1)
PIK3CA mutation + HR positive + HER-2 negative (1)
PIK3CA mutation + IDH2 mutation + Chr del(1q) + Chr del(17) (1)
PIK3CA mutation + PTEN underexpression (1)
PIK3CA mutation + RAS wild-type (1)
PIK3CA mutation + TTN mutation + IDH2 mutation + Chr del(1q) + Chr del(17) (1)
PIK3CA wild-type+ ESR1 wild-type (1)
SQSTM1-NTRK1 + PIK3CA E545K + TP53 L145R + PD-L1 overexpression (1)
ER negative + HER-2 positive + PIK3CA H1047R (0)
MYB fusion + PIK3CA amplification (0)
PIK3CA E453K + HER-2 positive (0)
PIK3CA E542K + HER-2 positive (0)
PIK3CA E542Q + HER-2 positive (0)
PIK3CA H1047L + HER-2 positive (0)
PIK3CA H1047R + HER-2 positive (0)
PIK3CA N345K + HER-2 positive (0)
PIK3CA amplification + HER-2 positive (0)
PIK3CA amplification + PTEN deletion (0)
PIK3CA mutation + ER negative + PGR positive (0)
PIK3CA mutation + PTEN expression (0)
PIK3CA mutation + TMB-L + MSI-L/dMMR (0)
PIK3CA mutation + HR positive (16)
PIK3CA mutation + ER positive (10)
PIK3CA mutation + PTEN deletion (5)
ER positive + PIK3CA H1047R (3)
HR-positive + PIK3CA wild-type (3)
PIK3CA exon 20 mutation + HR positive (3)
BRAF V600E + PIK3CA mutation + SMAD4 mutation + MSI-H/dMMR (2)
PIK3CA mutation + ER negative (2)
PIK3CA mutation + HR negative (2)
PIK3CA mutation + MSI-L/dMMR (2)
TMB-H + PIK3CA mutation (2)
CCNE1 overexpression + PIK3CA muattion + ER positive (1)
CCNE2 overexpression + PIK3CA mutation + ER positive (1)
EGFR L858R + HER-2 amplification + PIK3CA overexpression (1)
EGFR exon 19 deletion + PTEN deletion + PIK3CA overexpression (1)
ER negative + HER-2 positive + PGR positive + PIK3CA mutation (1)
ER positive + ESR1 mutation + PIK3CA mutation (1)
ESR1 mutation + PIK3CA mutation + HR positive (1)
HR positive + PIK3CA exon 10 mutation (1)
HRAS overexpression + PIK3CA amplification (1)
HRAS overexpression + PIK3CA mutation (1)
KRAS mutation + PIK3CA wild-type (1)
MET amplification + PIK3CA mutation (1)
MTAP deletion + PIK3CA mutation (1)
MYB fusion + PIK3CA mutation (1)
PD-L1 expression + PIK3CA mutation (1)
PIK3CA E542K + HR positive (1)
PIK3CA E542Q + TMB-H + MSI-H/dMMR (1)
PIK3CA H1047R + HER-2 amplification (1)
PIK3CA R88Q + PD-L1 expression (1)
PIK3CA amplification + PIK3CA mutation + HR positive (1)
PIK3CA exon 7 mutation + HR positive (1)
PIK3CA exon 9 mutation + HR positive (1)
PIK3CA mutation + ALK fusion (1)
PIK3CA mutation + ALK positive (1)
PIK3CA mutation + BRAF wild-type (1)
PIK3CA mutation + ESR1 wild-type (1)
PIK3CA mutation + HER-2 amplification (1)
PIK3CA mutation + HER-2 positive (1)
PIK3CA mutation + HR positive + HER-2 negative (1)
PIK3CA mutation + IDH2 mutation + Chr del(1q) + Chr del(17) (1)
PIK3CA mutation + PTEN underexpression (1)
PIK3CA mutation + RAS wild-type (1)
PIK3CA mutation + TTN mutation + IDH2 mutation + Chr del(1q) + Chr del(17) (1)
PIK3CA wild-type+ ESR1 wild-type (1)
SQSTM1-NTRK1 + PIK3CA E545K + TP53 L145R + PD-L1 overexpression (1)
ER negative + HER-2 positive + PIK3CA H1047R (0)
MYB fusion + PIK3CA amplification (0)
PIK3CA E453K + HER-2 positive (0)
PIK3CA E542K + HER-2 positive (0)
PIK3CA E542Q + HER-2 positive (0)
PIK3CA H1047L + HER-2 positive (0)
PIK3CA H1047R + HER-2 positive (0)
PIK3CA N345K + HER-2 positive (0)
PIK3CA amplification + HER-2 positive (0)
PIK3CA amplification + PTEN deletion (0)
PIK3CA mutation + ER negative + PGR positive (0)
PIK3CA mutation + PTEN expression (0)
PIK3CA mutation + TMB-L + MSI-L/dMMR (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
PIK3CA H1047R + PIK3C2B amplification
Breast Cancer
PIK3CA H1047R + PIK3C2B amplification
Breast Cancer
alpelisib
Sensitive: C4 – Case Studies
alpelisib
Sensitive
:
C4
alpelisib
Sensitive: C4 – Case Studies
alpelisib
Sensitive
:
C4
PIK3CA H1047R + PIK3C2B amplification
Breast Cancer
PIK3CA H1047R + PIK3C2B amplification
Breast Cancer
palbociclib
Resistant: C4 – Case Studies
palbociclib
Resistant
:
C4
palbociclib
Resistant: C4 – Case Studies
palbociclib
Resistant
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.